Ledger.Open graph →
SEC Form D · filed December 28, 2020

Quellis Biosciences, Inc

Offering
$1.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jonathan Violin · Waltham, MAExec · DirectorFrederick Callori · Waltham, MADirectorChristopher Garabedian · Philadelphia, PADirectorJonathan Poma · Columbus, OHExec · DirectorValerie M. Bauer Gore · Columbus, OHDirectorVijay W. Palkar · New York, NYExec · DirectorLouise W. Smith · Richmond, VADirectorChristopher Garabedian · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗